Related references
Note: Only part of the references are listed.Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette et al.
JOURNAL OF HEPATOLOGY (2021)
Regulation of Caspase-8 Activity at the Crossroads of Pro-Inflammation and Anti-Inflammation
Jun-Hyuk Han et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Li Duan et al.
FRONTIERS IN GENETICS (2021)
Inhibitory effect of PPARγ on NLRP3 inflammasome activation
Ching-Chun Yang et al.
THERANOSTICS (2021)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Caspase-1 as a regulatory molecule of lipid metabolism
Meseret Derbew Molla et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Effect of caspase inhibitor Z-VAD-FMK on bovine sperm cryotolerance
Nunzia Pagano et al.
REPRODUCTION IN DOMESTIC ANIMALS (2020)
New insights into the regulation of apoptosis, necroptosis, and pyroptosis by receptor interacting protein kinase 1 and caspase-8
Robin Schwarzer et al.
CURRENT OPINION IN CELL BIOLOGY (2020)
Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?
Vignayanandam Ravindernath Muddapu et al.
FRONTIERS IN NEUROSCIENCE (2020)
Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
Joseph Flores et al.
NATURE COMMUNICATIONS (2020)
BH3 Mimetics for the Treatment of B-Cell Malignancies-Insights and Lessons from the Clinic
Victor S. Lin et al.
CANCERS (2020)
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2019)
Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells
Marcin Poreba et al.
CELL DEATH AND DIFFERENTIATION (2019)
Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch et al.
IMMUNITY (2019)
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2019)
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
Melanie Fritsch et al.
NATURE (2019)
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
Mitchell Shiffman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice
Lazaro Emilio Aira et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2019)
Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection
Yang-Ding Lin et al.
FRONTIERS IN IMMUNOLOGY (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Apoptosis: A Target for Anticancer Therapy
Claire M. Pfeffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques
Mireille Laforge et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
To die or not to die: death signaling in nonalcoholic fatty liver disease
Yuko Akazawa et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies
E. A. van Vliet et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Ju Youn Kim et al.
CELL (2018)
CRISPR-Cas9: A New Addition to the Drug Metabolism and Disposition Tool Box
M. Karlgren et al.
DRUG METABOLISM AND DISPOSITION (2018)
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model
Joseph Flores et al.
NATURE COMMUNICATIONS (2018)
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Merino et al.
CANCER CELL (2018)
Caspase inhibitors: a review of recently patented compounds (2013-2015)
Hyemin Lee et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Apoptosis-induced lymphopenia in sepsis and other severe injuries
Thibaut Girardot et al.
APOPTOSIS (2017)
Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
Zhiyuan Niu et al.
NATURE COMMUNICATIONS (2017)
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors
Christina E. Smith et al.
CELL CHEMICAL BIOLOGY (2017)
Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice
M. C. Morrison et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
Gabriela Brumatti et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease
M. V. Machado et al.
CELL DEATH & DISEASE (2016)
Increased apoptosis and browning of TAK1-deficient adipocytes protects against obesity
Antonia Sassmann-Schweda et al.
JCI INSIGHT (2016)
Small Molecule Active Site Directed Tools for Studying Human Caspases
Marcin Poreba et al.
CHEMICAL REVIEWS (2015)
Isatin sulfonamides: potent caspases-3 and-7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imaging
Panupun Limpachayaporn et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds
Saif Khan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Petra Hirsova et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Immunology of Psoriasis
Michelle A. Lowes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Saeid Ghavami et al.
PROGRESS IN NEUROBIOLOGY (2014)
Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
Elisabeth C. R. Solano et al.
NUCLEIC ACID THERAPEUTICS (2014)
Targeting caspases in cancer therapeutics
Patrick Hensley et al.
BIOLOGICAL CHEMISTRY (2013)
Caspase Induction and BCL2 Inhibition in Human Adipose Tissue A potential relationship with insulin signaling alteration
Francisco Jose Tinahones et al.
DIABETES CARE (2013)
Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
Meir Bialer et al.
EPILEPSY RESEARCH (2013)
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Caspase Functions in Cell Death and Disease
David R. McIlwain et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Caspase Substrates and Inhibitors
Marcin Poreba et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries
Aruni S. Arachchige Don et al.
DRUG DISCOVERY TODAY (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury
Chun-Shu Piao et al.
NEUROBIOLOGY OF DISEASE (2012)
Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1
L. W. Wood et al.
CANCER GENE THERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inflammation in epilepsy: Clinical observations
Eleonora Aronica et al.
EPILEPSIA (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
Marcello D'Amelio et al.
NATURE NEUROSCIENCE (2011)
Allosteric modulation of caspases
Hans-Georg Haecker et al.
PHARMACOLOGY & THERAPEUTICS (2011)
The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice
Michael McCall et al.
SURGERY (2011)
Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor
D. Chauvier et al.
CELL DEATH & DISEASE (2011)
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities
Troy T. Rohn
APOPTOSIS (2010)
THE ROLES OF P38MAPK AND CASPASE-3 IN DADS-INDUCED APOPTOSIS IN HUMAN HEPG2 CELLS
Chunxiao Ji et al.
ARCHIVES OF BIOLOGICAL SCIENCES (2010)
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
Rinke Stienstra et al.
CELL METABOLISM (2010)
A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety
Matthew B. Boxer et al.
CHEMMEDCHEM (2010)
Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival
Juliet A. Emamaullee et al.
DIABETES (2010)
Insights Into Sepsis Therapeutic Design Based on the Apoptotic Death Pathway
Yuichi Hattori et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Small-molecule caspase inhibitors
S. M. Zhenodarova
RUSSIAN CHEMICAL REVIEWS (2010)
Apoptosis as a Mechanism for Liver Disease Progression
Maria Eugenia Guicciardi et al.
SEMINARS IN LIVER DISEASE (2010)
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Mads Gyrd-Hansen et al.
NATURE REVIEWS CANCER (2010)
P38MAPK regulates caspase-3 by binding to caspase-3 in nucleus of human hepatoma Bel-7402 cells during anti-Fas antibody- and actinomycin D-induced apoptosis
Yu Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
The Jekyll and Hyde Functions of Caspases
Caroline H. Yi et al.
DEVELOPMENTAL CELL (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor
Luigi Moretti et al.
MOLECULAR CANCER THERAPEUTICS (2009)
VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis
Peter Weber et al.
CRITICAL CARE (2009)
Dual Involvement of Caspase-4 in Inflammatory and ER Stress-Induced Apoptotic Responses in Human Retinal Pigment Epithelial Cells
Zong-Mei Bian et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
The caspase selective inhibitor EP1013 augments human islet graft function arid longevity in marginal mass islet transplantation in mice
Juliet A. Emamaullee et al.
DIABETES (2008)
Caspases as therapeutic targets
B. Howley et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Therapeutic efficacy of Ac-DMQD-CHO, a caspase 3 inhibitor, for rat spinal cord injury
Osman Akdemir et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Effect of Boc-D-Fmk on hepatocyte apoptosis after bile duct ligation in rat and survival rate after endotoxin challenge
Shyr-Ming Sheen-Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Caspases: Structure-Guided Design of Drugs to Control Cell Death
Irene T. Weber et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
M867, a Novel Selective Inhibitor of Caspase-3 Enhances Cell Death and Extends Tumor Growth Delay in Irradiated Lung Cancer Models
Kwang Woon Kim et al.
PLOS ONE (2008)
Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury
Bruce A. Citron et al.
SPINE (2008)
p38 MAPK plays an essential role in apoptosis induced by photoactivation of a novel ethylene glycol porphyrin derivative
J. Kralova et al.
ONCOGENE (2008)
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18
Woods Wannamaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation
Juliet A. Emamaullee et al.
DIABETES (2007)
Essential role for caspase-8 in toll-like receptors and NFκB signaling
Benedicte Lemmers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Broad-spectrum caspase inhibitors: from myth to reality?
D. Chauvier et al.
CELL DEATH AND DIFFERENTIATION (2007)
Caspase inhibitors: viral, cellular and chemical
B. A. Callus et al.
CELL DEATH AND DIFFERENTIATION (2007)
Inhibition of caspase-1/interleukin-1 beta signaling prevents degeneration of retinal capillaries in diabetes galactosemia
Jason A. Vincent et al.
DIABETES (2007)
Apoptosis and caspases regulate death and inflammation in sepsis
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Inactivation of caspase-1 in rodent brain:: A novel anticonvulsive strategy
Teresa Ravizza et al.
EPILEPSIA (2006)
Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis
Darryl D'Lima et al.
ARTHRITIS AND RHEUMATISM (2006)
Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice
Caroline Oberhotzer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Caspase-2, a novel lipid sensor under the control of sterol regulatory element binding protein 2
E Logette et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Apoptosis-based therapies and drug targets
U Fischer et al.
CELL DEATH AND DIFFERENTIATION (2005)
Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury
A Çolak et al.
JOURNAL OF NEUROSURGERY-SPINE (2005)
Specificity and reactive loop length requirements for crmA inhibition of serine proteases
LD Tesch et al.
PROTEIN SCIENCE (2005)
Caspase inhibitors: A pharmaceutical industry perspective
SD Linton
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Inhibitors of TACE and Caspase-1 as anti-inflammatory drugs
GT Le et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Characterization of IDN-6556(3-{2-(2-tert-butylphenylaminooxalyl)amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic Acid): a liver-targeted caspase inhibitor
NC Hoglen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The p35 family of apoptosis inhibitors
AM Jabbour et al.
CURRENT GENOMICS (2004)
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease
S Toulmond et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Discovery of an allosteric site in the caspases
JA Hardy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo
LC Yang et al.
NEUROBIOLOGY OF DISEASE (2004)
The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model
H Inoue et al.
EMBO JOURNAL (2003)
The inhibitors of apoptosis: there is more to life than Bcl2
P Liston et al.
ONCOGENE (2003)
High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons
HH Slagsvold et al.
BRAIN RESEARCH (2003)
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties
TM Caserta et al.
APOPTOSIS (2003)
Mechanisms of disease: Apoptosis and caspases in neurodegenerative diseases
RM Friedlander
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones
DS Campbell et al.
NEURON (2003)
Apoptosis in Parkinson's disease: Signals for neuronal degradation
WG Tatton et al.
ANNALS OF NEUROLOGY (2003)
To kill or be killed: viral evasion of apoptosis
CA Benedict et al.
NATURE IMMUNOLOGY (2002)
Caspase activation in retinas of diabetic and galactosentic mice and diabetic patients
S Mohr et al.
DIABETES (2002)
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease
V Viswanath et al.
JOURNAL OF NEUROSCIENCE (2001)
How do neurons die in neurodegenerative diseases?
I Kanazawa
TRENDS IN MOLECULAR MEDICINE (2001)
Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP
J Silke et al.
EMBO JOURNAL (2001)
Structural basis of caspase-7 inhibition by XIAP
JJ Chai et al.
CELL (2001)
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
H Turmel et al.
MOVEMENT DISORDERS (2001)
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity
S Fiorucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded
JP Julien
CELL (2001)
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
RS Hotchkiss et al.
NATURE IMMUNOLOGY (2000)
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
MW Li et al.
SCIENCE (2000)
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury
MM Mocanu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Caspase-3 mediated neuronal death after traumatic brain injury in rats
RSB Clark et al.
JOURNAL OF NEUROCHEMISTRY (2000)